Prolonged Postoperative Opioid Use Noted in Early-Stage Breast Cancer
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.
Prescription drug monitoring programs that aim to prevent opioid misuse may be affecting patients with cancer who need pain management.
Expertise in the use of nonpharmacologic pain management techniques and therapies allow masters-prepared social workers to be an integral member of a multidisciplinary cancer care team.
Opioid-related deaths in the cancer population are much rarer than in the general population.
Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.
Strontium89 (Strontium Chloride Sr-89 injection), a radiopharmaceutical indicated for the relief of bone pain in patients with painful skeletal metastases, has been made available by Q BioMed.
The use of acupuncture and/or acupressure is associated with reduced cancer pain and decreased use of analgesics.
Among cancer survivors, demographic, cancer, and treatment factors can predict adverse opioid-related outcomes.
Between 2005 and 2015, there was a more than twofold increase in the percentage of adults with cancer using gabapentinoids.